Solventum Corporation announced fourth-quarter earnings of $1.57 per share, exceeding analyst expectations by 4.9%, but faced a revenue decline to $2 billion, down 3.7% year-over-year. Adjusted gross profit also decreased by 8.3% to $1.07 billion, raising concerns about the company's liquidity with cash reserves plummeting to $8.78 million. Despite these challenges, Solventum predicts organic sales growth of 3-4% for 2026, indicating a potential recovery trajectory.
“Solventum · reported · adjusted earnings per share · $1.57”
“Solventum · reported · sales · $2 billion”
“Solventum SOLV · reported · fourth-quarter 2025 adjusted earnings per share (EPS) · $1.57”
“Zacks Consensus Estimate · was beaten by · Solventum SOLV · 4.7%”
“Revenue · was reported by · Solventum SOLV · $1.99 billion”
“Solventum SOLV · experienced organic sales growth of · 3.5% · year over year”
“Solventum SOLV · reported adjusted gross profit of · $1.07 billion · down 8.3% year over year”
“Solventum SOLV · exited the fourth quarter with cash, cash equivalents and investments of · $8.78 million · compared with $1.64 billion in the previous quarter”
“Solventum SOLV · provided its guidance for 2026 organic sales growth at · the higher end of 2-3% · 3-4% excluding 100bps of SKU Exit impact”
“Solventum SOLV · is scheduled to release · fourth-quarter 2025 results · on Feb. 26, after market close”
“Solventum · beat the Zacks Consensus Estimate · in the last reported quarter · by 4.90%”
“Solventum · delivered a trailing four-quarter average earnings surprise · of 10.42%”
